Endocrine Society
October 16, 2008 

On September 8, 2008 the first results from the Juvenile Diabetes Research Foundation's (JDRF) independent trial to assess the effectiveness of continuous glucose monitoring (CGM) were presented at the European Association for the Study of Diabetes meeting and published in the New England Journal of Medicine.  The results show that patients with type 1 diabetes who used CGM devices to help manage their disease experienced significant improvements in blood sugar control.  For more information on the findings of the trial, please click here.

JDRF has launched a campaign to encourage health plans to cover CGM and has requested that Society members participate.  Since health plans are most likely to make coverage changes only after hearing directly from medical professionals in their network, the first step to supporting this campaign is for physician members to simply provide their contact information and identify the health care networks with which they are associated by visiting the following link:

http://takeaction.jdrf.org/PatientCGMCoverage

Anyone who joins JDRF's CGM Coverage Campaign will receive timely information on campaign progress and on additional ways to help make CGM technology available for everyone.